Furthermore, the genetic variance within these genes was also associated with Aβ and tau levels in CSF [38,39,40,41] and blood plasma [42,43]; therefore, our study focused on common functional polymorphisms in established AD risk loci. This evidence concerns the gene MAPT and Alzheimer disease.